Recently, MEF2C mutations were founded in patients with heart disorders, including patent ductus arteriousus (PDA), double outlet right ventricle (DORV), ventricular septal defect (VSD) and dilated cardiomyopathy (DCM), accompanied with or without neurological symptoms [19–21]. Here, MEF2C is linked to ventricular septal defect 1.